Notably, immunodeficient B-NDG mice with immortalized lymphoblastoid cell line (LCL) tumors treated with RIG-I shRNA knockout human CD8+ T cells exhibited delayed tumor progression, with increased frequencies of cytolytic TIL (68). This evidence concerns the gene RIGI and neoplasm.